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This Month in the Journal
This month in the Journal, Kristin Waite and Charis Eng
(p. 829) present a review of the tumor-suppressor gene
PTEN. Along with an overview of the spectrum of dis-
eases in which it is known to be mutated, Waite and
Eng discuss PTEN’s phosphatase activities and the role
that this multitalented protein may have in the PI3K,
MAP kinase, insulin signaling, and other pathways.
Rapsyn Mutations in Humans, by Ohno et al. (p. 875)
Congenital myasthenic syndromes (CMS), characterized
by muscle weakness, result from defects in endplate-spe-
cific proteins. CMS-associated mutations are found in
the genes for choline acetyltransferase, an acetylcholin-
esterase subunit, and the acetylcholine receptor (AChR)
subunits. Ohno et al. find 10 patients who do not carry
mutations in these genes, so they decide to expand their
search for mutations. The researchers focus on the gene
for rapsyn, RAPSN, because, in the postsynaptic mem-
brane of the motor endplate, it binds to the AChR and
links it to the subsynaptic cytoskeleton. Three mutations
are identified in four of these patients, including two
missense mutations and a small insertion. Endplate stud-
ies indicate that these individuals have AChR and rapsyn
deficiencies and impaired morphologic development of
the postsynaptic region but no evidence of decreased
acetylcholine release in response to nerve impulse. In a
cell-culture system, the RAPSN mutations significantly
compromise AChR recruitment to rapsyn clusters. The
severity of disease in these patients is variable, even be-
tween two patients who possess identical homozygous
mutations, leading the authors to propose that poly-
morphisms in functionally related genes may play a role
in phenotypic expression of this disorder.
SOS1 Mutation Causes HGF1, by Hart et al. (p. 943)
Hart et al. have identified the first mutation associated
with nonsyndromic hereditary gingival fibromatosis
(HGF). This is a benign fibrous enlargement of the gin-
giva that, in severe cases, can prevent tooth eruption.
By use of a very large affected family, they are able to
limit the critical region on chromosome 2p21-p22 to
∼2.3 Mb. Sixteen genes in this critical region were se-
quenced, and only one polymorphism was found to seg-
regate with the HGF phenotype. The polymorphism is
a 1-base insertion in the Son of sevenless-1 gene (SOS1),
and it is predicted to cause a frameshift and premature
truncation of the protein. HGF1 segregates as an au-
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tosomal dominant trait in this family, and both normal
and mutant SOS1 transcripts were demonstrated in the
gingival tissue and white blood cells of affected individ-
uals. The mutation appears to remove functional do-
mains that maintain SOS1, a guanine nucleotide ex-
change factor, in a downregulated state. On the basis of
previous studies of SOS1 carboxy terminal truncations
in a variety of systems, it is believed that this mutation
leads to a gain of function, although the mechanism by
which it results in gingival overgrowth and the reason
for its tissue specificity are, as yet, unknown.
Increased Alternative Splicing Causes Cardiac Fabry
Disease (Report), by Ishii et al. (p. 994)
Ishii et al. describe a mutation, in individuals with car-
diac Fabry disease, that substantially increases alterna-
tive splicing of RNA transcribed from the causative gene.
Fabry disease is an inborn error of glycosphingolipid
catabolism resulting from an a-galactosidase A (a-Gal
A) deficiency. The cardiac form of Fabry disease is a
relatively mild form of the disease, presumably due to
residual a-Gal A activity, that generally presents with
left ventricular hypertrophy and late-onset cardiomy-
opathy. In six patients with cardiac Fabry disease, an
intronic mutation leads to inclusion of a 57-nt intronic
sequence in a-Gal A transcripts. This alternative exon
is used at low levels in normal human tissues and, in
lymphoblasts, at rates ∼10 times higher than normal
when the mutation is present. The authors propose that
this GrA mutation increases the A/C predominance in
an already A/C-rich sequence and that the sequence may
therefore serve as an A/C-rich exonic splicing enhancer.
No matter the mechanism, the presence of this mutation
in six people with the cardiac form of Fabry disease
suggests that it is a prevalent mutation that should be
considered in similar patients, particularly in the absence
of mutations in the coding and flanking regions of this
gene.
Premature Chromosome Condensation Syndrome
(Report), by Neitzel et al. (p. 1015)
Neitzel et al. describe a unique, autosomal recessive cell-
cycle disorder in a pair of siblings with microcephaly,
profound mental retardation, and growth retardation.
The disorder is characterized by premature chromosome
condensation with a high rate of prophase-like cells that
retain their nuclear membranes. Additional cell-cycle
analyses did not indicate a prolongation of the G2/M
phase, increased radiosensitivity, or malsegregation of
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chromosomes at anaphase. Although several factors are
known to play a role in the regulation of the affected
stages of the cell cycle, homozygosity mapping did not
implicate any of these known candidate genes in this
disorder. It is likely, therefore, that cell lines from these
patients will be useful in further dissection of cell-cycle
regulation and that they may lead to the identification
of a novel factor in the regulation of early prophase.
SNPs as Indicators of Deletions (Report), by Huie et
al. (p. 1054)
Huie et al. suggest that apparent homozygosity for mul-
tiple contiguous SNPs be considered as a potential in-
dicator of heterozygous deletions. Using this clue, they
successfully identify the second mutation in a patient
with autosomal recessive glycogen storage disease type
II, in whom only a single splice-site mutation had been
found by use of conventional methods. They noticed that
14 SNPs in the causative gene, GDSII, were apparently
homozygous in the proband. Primers flanking this “ho-
mozygous” region were used to amplify the region, yield-
ing a product much smaller than expected. Sequence
analysis confirmed an 8.26-kb deletion in GDSII. This
work shows how easy it can be to miss large deletions
by conventional PCR and sequencing methods, but it
also indicates that this problem can be overcome fairly
easily if apparent long-range homozygosity is examined
carefully. The authors also emphasize that apparent mu-
tation homozygosity in probands with nonconsanguin-
eous parents should be confirmed through the identifi-
cation of the mutation in both parents.
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